A newly published paper in the journal called The Prostate has described a type of previously unidentified cell that may indicate the presence of a more aggressive subtype of prostate cancer. … READ MORE …
Filed under: Diagnosis, Risk | Tagged: cell, histopathology, subtype, syndecan-1 | Leave a comment »
A paper just published in Cancer Research suggests that a particular ETS-negative subtype of prostate cancer (ERG−MAP3K7delCHD1del) is highly aggressive, and that coordinate loss of the MAP3K7 and CHD1 genes are potentially a unique driver of development of aggressive prostate cancer. … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk, Treatment | Tagged: aggressive, mortality, risk, subtype | 4 Comments »
The vast majority of prostate cancers are adenocarcinomas of the prostate, i.e., cancers that start in the epithelial cells of the prostate gland. Most of these adenocarcinomas have a well-defined, “normal” cancer histology. However, there are five categories of rare adenocarcinoma, with differing levels of risk. … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk | Tagged: adenocarcinoma, incidence, mortality, rare, subtype | Leave a comment »
A Letter to the Editor just published in the journal Nature Genetics has suggested that that so-called SPOP mutations may be responsible for between 6 and 15 percent of the prostate cancers diagnosed in the USA each year. … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk | Tagged: gene, mutation, SPOP, subtype, targeted | Leave a comment »
THE "NEW" PROSTATE CANCER INFOLINK 